SHIELD THERAPEUTICS PLC

Shield Therapeutics stock today: flat 0%, priced at GBX 5.3, 52‑week high GBX 12.5, 200‑day MA GBX 7.12. Explore its iron‑deficiency and hyperphosphatemia drugs on the London Stock Exchange.

Shield Therapeutics drops 1.8% as investors weigh its 200‑day SMA and upcoming iron‑deficiency drugs, trading at GBP 5.5 on the LSE.